Although pre-clinical evidence demonstrated reduction of pancreatic tumor-associated inflammation and desmoplasia through TNF-α inhibition, randomized clinical studies showed that modulation of TNF-alpha activity in PC patients did not produce any clinical benefit [164,165,166]. Here, TNF is linked to pancreatic neoplasm.